Try our Advanced Search for more refined results

June 29, 2021

Teva Pharmaceuticals International GmbH et al v. Accord Healthcare Inc.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. June 30, 2021

    Teva Says Intas Unit Seeks Cancer Drug Generic Far Too Soon

    Teva has hit a subsidiary of Intas Pharmaceuticals Ltd. with a patent suit in Delaware federal court, saying the unit filed too early to make and sell a generic version of Teva's leukemia and lymphoma drug Bendeka.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login